Medgend Icon

Ledgend of Medicine

MODERN MEDICINES

Prevent Pregnancy

Hypertension

Heart Disease

Cancer

Respiratory Disease

Stroke

Alzheimer's Disease

Diabetes

Influenza

Pneumonia

Kidney Disease

Depression

Anxiety

Synthroid

Lipitor

Ventolin

Nexium

Advair Diskus

Lantus Solostar

Vyvanse

Lyrica

Januvia

Abilify

Sovaldi

Enbrel

Harvoni

Lantus Solostar

Hemorrhoid

Yeast Infection

Lupus

Shingles

Psoriasis

Schizophrenia

Lyme Disease

Hpv

Herpes

Fibromyalgia

Scabies

Chlamydia

Endometriosis

Strep Throat

Diverticulitis

Bronchitis

Viagra

Cialis

Ibuprofen

Aspirin

Rogaine

Favilavir

Remdesivir

Chloroquine Phosphate

Kaletra

Hydroxychloroquine

HOME REMEDIES

Acne

Essential Oil

Nausea

Hiccups

Sore Throat

Cough

Fever

Skin Burn

Foot Odor

Cold

Bad Breath

Chapped Lips

Stiff Neck

Snoring

Insomnia

Puffy Eyes

Stained Teeth

Prevent Headache

Prevent Hangover

Menstrual Cramps

Prevent Vomiting

Cannot Sleep

Migraine Headache

Premenstrual Syndrome (pms)

Heartburn

Warts

Nail Fungus

Erectile Dysfunction

Coronavirus

Covid-19

RANDOM DRUGS

Alrex

Decitabine

Tobrasone

Acuvail

Catapres-tts-1

Diclegis

Butalibital, Acetaminophen And Caffeine

Temodar

Adenocard

Elmiron

RANDOM AILMENTS

Chapped Lips

Headache

Unclog Pores

Dry Chapped Skin

Flatulence

Rash In Babies

Skin Burn

Prevent Vomiting

Cannot Sleep

Prevent Hangover







discontinued


Amitiza FDA Approved Drugs

AMITIZA [LubiprostoneC20H32F2O5]
RX
-
24mcg (oral capsule)
8mcg (oral capsule)
Sucampo Pharma LlcJan 31, 2006
  • Method for relieving constipation in a human patient that comprises administering to the patient a dosage unit comprising (i) 24mcg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
  • Method for relieving constipation in a patient with opioid-induced constipation that comprises administering to the patient a dosage unit comprising(i)24microg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
  • Method for relieving or treating constipation in a human constipated patient.
  • Method for relieving or treating constipation in a patient with irritable bowel syndrome.
  • Method for relieving or treating constipation in a patient with opioid-induced constipation.
  • Method for the long term treatment of chronic constipation in a human subject with irritable bowel syndrome.
  • Method for the long term treatment of chronic constipation in a human subject.
  • Method for treating constipation by opening cic channels in a mammalian subject.
  • Method for treating constipation in a patient with opioid-induced constipation by opening cic channels.
  • Method for treating irritable bowel syndrome and method for treating abdominal discomfort associated with irritable bowel syndrome.
  • Method for treating opioid-induced constipation.
  • Method of relieving or preventing constipation in a human constipated patient.
  • Method of relieving or preventing constipation in a human patient with opioid-induced constipation.
  • Method of treating constipation in a patient with irritable bowel syndrome by opening chloride channels (cic).
  • Method of treating constipation in a patient with irritable bowel syndrome.
  • Use in relieving or preventing constipation in a human patient with a dosage unit comprising 24microg+/- 10% of a drug substance and a pharmaceutically suitable excipient.
  • Use in relieving or preventing constipation in a patient with opioid-induced constipation with a dosage unit comprising 24microg +/- 10% of a drug substance and a pharmaceutically suitable excipient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.